Table 4.
CD34+ cell therapy (n=7) | Historical control (n=11) | p-Value | |
---|---|---|---|
Age (range, years) | 33.9±7.8 (20–45) | 37.1±14.9 (21–56) | N.S. |
Tibia/Femur | 5/2 | 7/4 | N.S. |
Union rate at week 12 (%) | 5/7 (71.4%) | 2/11 (18.1%) | <0.01 |
N.S., not significant.
CD34+ cell therapy (n=7) | Historical control (n=11) | p-Value | |
---|---|---|---|
Age (range, years) | 33.9±7.8 (20–45) | 37.1±14.9 (21–56) | N.S. |
Tibia/Femur | 5/2 | 7/4 | N.S. |
Union rate at week 12 (%) | 5/7 (71.4%) | 2/11 (18.1%) | <0.01 |
N.S., not significant.